This article examines the evidence, explores possible causes, and provides practical strategies for prevention and management of muscle cramps during GLP-1 therapy
1/3 $43.00 100box $48.00 10box $50.00 1box Min
Start your intake FDA Approval Age Restrictions for GLP-1 Weight Loss Medications The FDA approved Wegovy (semaglutide for weight management) in 2021 for adults 18 and older with a BMI of 30 or higher, or BMI of 27 or higher with weight-related health conditions
1-7 Semaglutide, found in Ozempic and Wegovy, can be added to existing treatment regimens to improve glycemic control and induce weight loss
There are several other GLP-1 receptor agonists available on the market, and it can be helpful to compare semaglutide to these other options to determine which brand is right for you
GLP-1 medications are prescription-only medications and are only prescribed to type-2 diabetics and those with obesity